In vitro molecular characterization of the development of the K65R and M184V mutations in subtype CHIV-1

被引：0
|
作者：
Coutsinos, D. [1 ]
Invernizzi, C. F. [1 ]
Xu, H. [1 ]
Brenner, B. G. [1 ]
Wainberg, M. A. [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3A 2T5, Canada
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [21] Differences in enhanced susceptibilities to NNRTIs and to zidovudine (ZDV) in site directed mutants (SDMs) bearing K65R, L74V or M184V
    Chappey, C
    Coakley, E
    Limoli, K
    Whitcomb, I
    Parkin, N
    ANTIVIRAL THERAPY, 2005, 10 : S105 - S105
  • [22] Evaluation of MultiCode-RTx® real-time PCR system for detection of subpopulations of K65R and M184V HIV-1 mutant viruses
    Svarovskaia, ES
    Moser, MJ
    Prudent, JR
    Miller, MD
    Borroto-Esoda, K
    ANTIVIRAL THERAPY, 2005, 10 (04) : S44 - S44
  • [23] Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome
    Henry, Mireille
    Tourres, Christian
    Colson, Philippe
    Ravaux, Isabelle
    Poizot-Martin, Isabelle
    Tamalet, Catherine
    JOURNAL OF CLINICAL VIROLOGY, 2006, 37 (03) : 227 - 230
  • [24] HIV-1 reverse transcriptase M184V and R212 K combined mutations conconfer phenotypic resistance to stavudine
    Nicastri, E
    Sarmati, L
    Parisi, SG
    D'Ettorre, C
    Narciso, F
    Vullo, V
    Andreoni, M
    AIDS, 2000, 14 : S112 - S112
  • [25] HIV-1 subtype C viruses rapidly develop K65R
    Mark A Wainberg
    Florence Doualla-Bell
    Tedani Gaolatte
    Madisa Mine
    Max Essex
    Bluma Brenner
    Retrovirology, 3 (Suppl 1)
  • [26] HIV-1 subtype C viruses rapidly develop K65R
    Wainberg, Mark A.
    Doualla-Bell, Florence
    Gaolatte, Tedani
    Mine, Madisa
    Essex, Max
    Brenner, Bluma
    RETROVIROLOGY, 2006, 3
  • [27] Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021)
    Delaunay, C
    Brun-Vézinet, F
    Landman, R
    Collin, G
    Peytavin, G
    Trylesinski, A
    Flandre, P
    Miller, M
    Descamps, D
    JOURNAL OF VIROLOGY, 2005, 79 (15) : 9572 - 9578
  • [28] Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
    Byun, Hyeonah
    Papathanasopoulos, Maria Antonia
    Steegen, Kim
    Basson, Adriaan Erasmus
    VIRUSES-BASEL, 2024, 16 (12):
  • [29] Differential impact of mutations M184V, M184I and M184T in HIV-1 RT on entecavir incorporation and susceptibility
    Van Maarseveen, N. M.
    Bernatchez, J. A.
    De Jong, D.
    Schinazi, R. F.
    Gotte, M.
    Nijhuis, M.
    ANTIVIRAL THERAPY, 2011, 16 : A65 - A65
  • [30] The risks and incidence of K65R and L74V mutations and subsequent virologic responses
    Waters, Laura
    Nelson, Mark
    Mandalia, Sundhiya
    Bower, Mark
    Powles, Tom
    Gazzard, Brian
    Stebbing, Justin
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (01) : 96 - 100
12345